Medical Care
Global Hereditary Cancer Testing Market Research Report 2025
- Sep 06, 25
- ID: 492610
- Pages: 95
- Figures: 96
- Views: 3
This report aims to provide a comprehensive presentation of the global market for Hereditary Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Cancer Testing.
The Hereditary Cancer Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hereditary Cancer Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Cancer Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
Myriad
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Strand Life Sciences
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
Segment by Type
RNA Testing
DNA Testing
Segment by Application
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hereditary Cancer Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Hereditary Cancer Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hereditary Cancer Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Cancer Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
Myriad
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Strand Life Sciences
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
Segment by Type
RNA Testing
DNA Testing
Segment by Application
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hereditary Cancer Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 RNA Testing
1.2.3 DNA Testing
1.3 Market by Application
1.3.1 Global Hereditary Cancer Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2020-2031)
2.2 Global Hereditary Cancer Testing Growth Trends by Region
2.2.1 Global Hereditary Cancer Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hereditary Cancer Testing Historic Market Size by Region (2020-2025)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Region (2026-2031)
2.3 Hereditary Cancer Testing Market Dynamics
2.3.1 Hereditary Cancer Testing Industry Trends
2.3.2 Hereditary Cancer Testing Market Drivers
2.3.3 Hereditary Cancer Testing Market Challenges
2.3.4 Hereditary Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Revenue
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2020-2025)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2020-2025)
3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hereditary Cancer Testing Revenue
3.4 Global Hereditary Cancer Testing Market Concentration Ratio
3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2024
3.5 Global Key Players of Hereditary Cancer Testing Head office and Area Served
3.6 Global Key Players of Hereditary Cancer Testing, Product and Application
3.7 Global Key Players of Hereditary Cancer Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2020-2025)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2026-2031)
5 Hereditary Cancer Testing Breakdown Data by Application
5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2020-2025)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hereditary Cancer Testing Market Size (2020-2031)
6.2 North America Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hereditary Cancer Testing Market Size by Country (2020-2025)
6.4 North America Hereditary Cancer Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2020-2031)
7.2 Europe Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hereditary Cancer Testing Market Size by Country (2020-2025)
7.4 Europe Hereditary Cancer Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2020-2031)
8.2 Asia-Pacific Hereditary Cancer Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hereditary Cancer Testing Market Size (2020-2031)
9.2 Latin America Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hereditary Cancer Testing Market Size by Country (2020-2025)
9.4 Latin America Hereditary Cancer Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2020-2031)
10.2 Middle East & Africa Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ambry Genetics (Konica Minota)
11.1.1 Ambry Genetics (Konica Minota) Company Details
11.1.2 Ambry Genetics (Konica Minota) Business Overview
11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2020-2025)
11.1.5 Ambry Genetics (Konica Minota) Recent Development
11.2 Asper Biogene
11.2.1 Asper Biogene Company Details
11.2.2 Asper Biogene Business Overview
11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2020-2025)
11.2.5 Asper Biogene Recent Development
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Hereditary Cancer Testing Introduction
11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2020-2025)
11.3.5 Natera Recent Development
11.4 Caris Life Sciences
11.4.1 Caris Life Sciences Company Details
11.4.2 Caris Life Sciences Business Overview
11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025)
11.4.5 Caris Life Sciences Recent Development
11.5 BioReference Laboratories (GeneDx)
11.5.1 BioReference Laboratories (GeneDx) Company Details
11.5.2 BioReference Laboratories (GeneDx) Business Overview
11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2020-2025)
11.5.5 BioReference Laboratories (GeneDx) Recent Development
11.6 LabSolutions
11.6.1 LabSolutions Company Details
11.6.2 LabSolutions Business Overview
11.6.3 LabSolutions Hereditary Cancer Testing Introduction
11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2020-2025)
11.6.5 LabSolutions Recent Development
11.7 Progenity，Inc
11.7.1 Progenity，Inc Company Details
11.7.2 Progenity，Inc Business Overview
11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2020-2025)
11.7.5 Progenity，Inc Recent Development
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Details
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2020-2025)
11.8.5 ARUP Laboratories Recent Development
11.9 Myriad
11.9.1 Myriad Company Details
11.9.2 Myriad Business Overview
11.9.3 Myriad Hereditary Cancer Testing Introduction
11.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2020-2025)
11.9.5 Myriad Recent Development
11.10 NeoGenomics
11.10.1 NeoGenomics Company Details
11.10.2 NeoGenomics Business Overview
11.10.3 NeoGenomics Hereditary Cancer Testing Introduction
11.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.10.5 NeoGenomics Recent Development
11.11 Blueprint Genetics
11.11.1 Blueprint Genetics Company Details
11.11.2 Blueprint Genetics Business Overview
11.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction
11.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.11.5 Blueprint Genetics Recent Development
11.12 CellMax Life
11.12.1 CellMax Life Company Details
11.12.2 CellMax Life Business Overview
11.12.3 CellMax Life Hereditary Cancer Testing Introduction
11.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2020-2025)
11.12.5 CellMax Life Recent Development
11.13 Fulgent Genetics
11.13.1 Fulgent Genetics Company Details
11.13.2 Fulgent Genetics Business Overview
11.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction
11.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.13.5 Fulgent Genetics Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Details
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction
11.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025)
11.14.5 Strand Life Sciences Recent Development
11.15 Myogenes
11.15.1 Myogenes Company Details
11.15.2 Myogenes Business Overview
11.15.3 Myogenes Hereditary Cancer Testing Introduction
11.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2020-2025)
11.15.5 Myogenes Recent Development
11.16 LabCorp
11.16.1 LabCorp Company Details
11.16.2 LabCorp Business Overview
11.16.3 LabCorp Hereditary Cancer Testing Introduction
11.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2020-2025)
11.16.5 LabCorp Recent Development
11.17 Quest Diagnostics
11.17.1 Quest Diagnostics Company Details
11.17.2 Quest Diagnostics Business Overview
11.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction
11.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.17.5 Quest Diagnostics Recent Development
11.18 Pathway Genomics
11.18.1 Pathway Genomics Company Details
11.18.2 Pathway Genomics Business Overview
11.18.3 Pathway Genomics Hereditary Cancer Testing Introduction
11.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.18.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 RNA Testing
1.2.3 DNA Testing
1.3 Market by Application
1.3.1 Global Hereditary Cancer Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2020-2031)
2.2 Global Hereditary Cancer Testing Growth Trends by Region
2.2.1 Global Hereditary Cancer Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hereditary Cancer Testing Historic Market Size by Region (2020-2025)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Region (2026-2031)
2.3 Hereditary Cancer Testing Market Dynamics
2.3.1 Hereditary Cancer Testing Industry Trends
2.3.2 Hereditary Cancer Testing Market Drivers
2.3.3 Hereditary Cancer Testing Market Challenges
2.3.4 Hereditary Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Revenue
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2020-2025)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2020-2025)
3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hereditary Cancer Testing Revenue
3.4 Global Hereditary Cancer Testing Market Concentration Ratio
3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2024
3.5 Global Key Players of Hereditary Cancer Testing Head office and Area Served
3.6 Global Key Players of Hereditary Cancer Testing, Product and Application
3.7 Global Key Players of Hereditary Cancer Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2020-2025)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2026-2031)
5 Hereditary Cancer Testing Breakdown Data by Application
5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2020-2025)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hereditary Cancer Testing Market Size (2020-2031)
6.2 North America Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hereditary Cancer Testing Market Size by Country (2020-2025)
6.4 North America Hereditary Cancer Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2020-2031)
7.2 Europe Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hereditary Cancer Testing Market Size by Country (2020-2025)
7.4 Europe Hereditary Cancer Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2020-2031)
8.2 Asia-Pacific Hereditary Cancer Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hereditary Cancer Testing Market Size (2020-2031)
9.2 Latin America Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hereditary Cancer Testing Market Size by Country (2020-2025)
9.4 Latin America Hereditary Cancer Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2020-2031)
10.2 Middle East & Africa Hereditary Cancer Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ambry Genetics (Konica Minota)
11.1.1 Ambry Genetics (Konica Minota) Company Details
11.1.2 Ambry Genetics (Konica Minota) Business Overview
11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2020-2025)
11.1.5 Ambry Genetics (Konica Minota) Recent Development
11.2 Asper Biogene
11.2.1 Asper Biogene Company Details
11.2.2 Asper Biogene Business Overview
11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2020-2025)
11.2.5 Asper Biogene Recent Development
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Hereditary Cancer Testing Introduction
11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2020-2025)
11.3.5 Natera Recent Development
11.4 Caris Life Sciences
11.4.1 Caris Life Sciences Company Details
11.4.2 Caris Life Sciences Business Overview
11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025)
11.4.5 Caris Life Sciences Recent Development
11.5 BioReference Laboratories (GeneDx)
11.5.1 BioReference Laboratories (GeneDx) Company Details
11.5.2 BioReference Laboratories (GeneDx) Business Overview
11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2020-2025)
11.5.5 BioReference Laboratories (GeneDx) Recent Development
11.6 LabSolutions
11.6.1 LabSolutions Company Details
11.6.2 LabSolutions Business Overview
11.6.3 LabSolutions Hereditary Cancer Testing Introduction
11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2020-2025)
11.6.5 LabSolutions Recent Development
11.7 Progenity，Inc
11.7.1 Progenity，Inc Company Details
11.7.2 Progenity，Inc Business Overview
11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2020-2025)
11.7.5 Progenity，Inc Recent Development
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Details
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2020-2025)
11.8.5 ARUP Laboratories Recent Development
11.9 Myriad
11.9.1 Myriad Company Details
11.9.2 Myriad Business Overview
11.9.3 Myriad Hereditary Cancer Testing Introduction
11.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2020-2025)
11.9.5 Myriad Recent Development
11.10 NeoGenomics
11.10.1 NeoGenomics Company Details
11.10.2 NeoGenomics Business Overview
11.10.3 NeoGenomics Hereditary Cancer Testing Introduction
11.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.10.5 NeoGenomics Recent Development
11.11 Blueprint Genetics
11.11.1 Blueprint Genetics Company Details
11.11.2 Blueprint Genetics Business Overview
11.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction
11.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.11.5 Blueprint Genetics Recent Development
11.12 CellMax Life
11.12.1 CellMax Life Company Details
11.12.2 CellMax Life Business Overview
11.12.3 CellMax Life Hereditary Cancer Testing Introduction
11.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2020-2025)
11.12.5 CellMax Life Recent Development
11.13 Fulgent Genetics
11.13.1 Fulgent Genetics Company Details
11.13.2 Fulgent Genetics Business Overview
11.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction
11.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.13.5 Fulgent Genetics Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Details
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction
11.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025)
11.14.5 Strand Life Sciences Recent Development
11.15 Myogenes
11.15.1 Myogenes Company Details
11.15.2 Myogenes Business Overview
11.15.3 Myogenes Hereditary Cancer Testing Introduction
11.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2020-2025)
11.15.5 Myogenes Recent Development
11.16 LabCorp
11.16.1 LabCorp Company Details
11.16.2 LabCorp Business Overview
11.16.3 LabCorp Hereditary Cancer Testing Introduction
11.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2020-2025)
11.16.5 LabCorp Recent Development
11.17 Quest Diagnostics
11.17.1 Quest Diagnostics Company Details
11.17.2 Quest Diagnostics Business Overview
11.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction
11.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.17.5 Quest Diagnostics Recent Development
11.18 Pathway Genomics
11.18.1 Pathway Genomics Company Details
11.18.2 Pathway Genomics Business Overview
11.18.3 Pathway Genomics Hereditary Cancer Testing Introduction
11.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2020-2025)
11.18.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of RNA Testing
Table 3. Key Players of DNA Testing
Table 4. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hereditary Cancer Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Hereditary Cancer Testing Market Share by Region (2020-2025)
Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Hereditary Cancer Testing Market Share by Region (2026-2031)
Table 10. Hereditary Cancer Testing Market Trends
Table 11. Hereditary Cancer Testing Market Drivers
Table 12. Hereditary Cancer Testing Market Challenges
Table 13. Hereditary Cancer Testing Market Restraints
Table 14. Global Hereditary Cancer Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Hereditary Cancer Testing Market Share by Players (2020-2025)
Table 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2024)
Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Hereditary Cancer Testing, Headquarters and Area Served
Table 20. Global Key Players of Hereditary Cancer Testing, Product and Application
Table 21. Global Key Players of Hereditary Cancer Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hereditary Cancer Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Hereditary Cancer Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Hereditary Cancer Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Hereditary Cancer Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Hereditary Cancer Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Ambry Genetics (Konica Minota) Company Details
Table 47. Ambry Genetics (Konica Minota) Business Overview
Table 48. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
Table 49. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 50. Ambry Genetics (Konica Minota) Recent Development
Table 51. Asper Biogene Company Details
Table 52. Asper Biogene Business Overview
Table 53. Asper Biogene Hereditary Cancer Testing Product
Table 54. Asper Biogene Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 55. Asper Biogene Recent Development
Table 56. Natera Company Details
Table 57. Natera Business Overview
Table 58. Natera Hereditary Cancer Testing Product
Table 59. Natera Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 60. Natera Recent Development
Table 61. Caris Life Sciences Company Details
Table 62. Caris Life Sciences Business Overview
Table 63. Caris Life Sciences Hereditary Cancer Testing Product
Table 64. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 65. Caris Life Sciences Recent Development
Table 66. BioReference Laboratories (GeneDx) Company Details
Table 67. BioReference Laboratories (GeneDx) Business Overview
Table 68. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
Table 69. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 70. BioReference Laboratories (GeneDx) Recent Development
Table 71. LabSolutions Company Details
Table 72. LabSolutions Business Overview
Table 73. LabSolutions Hereditary Cancer Testing Product
Table 74. LabSolutions Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 75. LabSolutions Recent Development
Table 76. Progenity，Inc Company Details
Table 77. Progenity，Inc Business Overview
Table 78. Progenity，Inc Hereditary Cancer Testing Product
Table 79. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 80. Progenity，Inc Recent Development
Table 81. ARUP Laboratories Company Details
Table 82. ARUP Laboratories Business Overview
Table 83. ARUP Laboratories Hereditary Cancer Testing Product
Table 84. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 85. ARUP Laboratories Recent Development
Table 86. Myriad Company Details
Table 87. Myriad Business Overview
Table 88. Myriad Hereditary Cancer Testing Product
Table 89. Myriad Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 90. Myriad Recent Development
Table 91. NeoGenomics Company Details
Table 92. NeoGenomics Business Overview
Table 93. NeoGenomics Hereditary Cancer Testing Product
Table 94. NeoGenomics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 95. NeoGenomics Recent Development
Table 96. Blueprint Genetics Company Details
Table 97. Blueprint Genetics Business Overview
Table 98. Blueprint Genetics Hereditary Cancer Testing Product
Table 99. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 100. Blueprint Genetics Recent Development
Table 101. CellMax Life Company Details
Table 102. CellMax Life Business Overview
Table 103. CellMax Life Hereditary Cancer Testing Product
Table 104. CellMax Life Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 105. CellMax Life Recent Development
Table 106. Fulgent Genetics Company Details
Table 107. Fulgent Genetics Business Overview
Table 108. Fulgent Genetics Hereditary Cancer Testing Product
Table 109. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 110. Fulgent Genetics Recent Development
Table 111. Strand Life Sciences Company Details
Table 112. Strand Life Sciences Business Overview
Table 113. Strand Life Sciences Hereditary Cancer Testing Product
Table 114. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 115. Strand Life Sciences Recent Development
Table 116. Myogenes Company Details
Table 117. Myogenes Business Overview
Table 118. Myogenes Hereditary Cancer Testing Product
Table 119. Myogenes Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 120. Myogenes Recent Development
Table 121. LabCorp Company Details
Table 122. LabCorp Business Overview
Table 123. LabCorp Hereditary Cancer Testing Product
Table 124. LabCorp Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 125. LabCorp Recent Development
Table 126. Quest Diagnostics Company Details
Table 127. Quest Diagnostics Business Overview
Table 128. Quest Diagnostics Hereditary Cancer Testing Product
Table 129. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 130. Quest Diagnostics Recent Development
Table 131. Pathway Genomics Company Details
Table 132. Pathway Genomics Business Overview
Table 133. Pathway Genomics Hereditary Cancer Testing Product
Table 134. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 135. Pathway Genomics Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Hereditary Cancer Testing Picture
Figure 2. Global Hereditary Cancer Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hereditary Cancer Testing Market Share by Type: 2024 VS 2031
Figure 4. RNA Testing Features
Figure 5. DNA Testing Features
Figure 6. Global Hereditary Cancer Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Hereditary Cancer Testing Market Share by Application: 2024 VS 2031
Figure 8. Breast Cancer Case Studies
Figure 9. Gastrointestinal Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Respiratory/Lung Cancer Case Studies
Figure 12. Other Cancers Case Studies
Figure 13. Hereditary Cancer Testing Report Years Considered
Figure 14. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Hereditary Cancer Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Hereditary Cancer Testing Market Share by Region: 2024 VS 2031
Figure 17. Global Hereditary Cancer Testing Market Share by Players in 2024
Figure 18. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2024
Figure 20. North America Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 22. United States Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 26. Germany Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Hereditary Cancer Testing Market Share by Region (2020-2031)
Figure 34. China Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 42. Mexico Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 46. Turkey Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 50. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 51. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 52. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 53. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 54. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 55. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 56. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 57. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 58. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 59. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 60. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 61. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 62. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 63. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 64. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 65. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 66. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of RNA Testing
Table 3. Key Players of DNA Testing
Table 4. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hereditary Cancer Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Hereditary Cancer Testing Market Share by Region (2020-2025)
Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Hereditary Cancer Testing Market Share by Region (2026-2031)
Table 10. Hereditary Cancer Testing Market Trends
Table 11. Hereditary Cancer Testing Market Drivers
Table 12. Hereditary Cancer Testing Market Challenges
Table 13. Hereditary Cancer Testing Market Restraints
Table 14. Global Hereditary Cancer Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Hereditary Cancer Testing Market Share by Players (2020-2025)
Table 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2024)
Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Hereditary Cancer Testing, Headquarters and Area Served
Table 20. Global Key Players of Hereditary Cancer Testing, Product and Application
Table 21. Global Key Players of Hereditary Cancer Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hereditary Cancer Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Hereditary Cancer Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Hereditary Cancer Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Hereditary Cancer Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Hereditary Cancer Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Hereditary Cancer Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Ambry Genetics (Konica Minota) Company Details
Table 47. Ambry Genetics (Konica Minota) Business Overview
Table 48. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
Table 49. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 50. Ambry Genetics (Konica Minota) Recent Development
Table 51. Asper Biogene Company Details
Table 52. Asper Biogene Business Overview
Table 53. Asper Biogene Hereditary Cancer Testing Product
Table 54. Asper Biogene Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 55. Asper Biogene Recent Development
Table 56. Natera Company Details
Table 57. Natera Business Overview
Table 58. Natera Hereditary Cancer Testing Product
Table 59. Natera Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 60. Natera Recent Development
Table 61. Caris Life Sciences Company Details
Table 62. Caris Life Sciences Business Overview
Table 63. Caris Life Sciences Hereditary Cancer Testing Product
Table 64. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 65. Caris Life Sciences Recent Development
Table 66. BioReference Laboratories (GeneDx) Company Details
Table 67. BioReference Laboratories (GeneDx) Business Overview
Table 68. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
Table 69. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 70. BioReference Laboratories (GeneDx) Recent Development
Table 71. LabSolutions Company Details
Table 72. LabSolutions Business Overview
Table 73. LabSolutions Hereditary Cancer Testing Product
Table 74. LabSolutions Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 75. LabSolutions Recent Development
Table 76. Progenity，Inc Company Details
Table 77. Progenity，Inc Business Overview
Table 78. Progenity，Inc Hereditary Cancer Testing Product
Table 79. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 80. Progenity，Inc Recent Development
Table 81. ARUP Laboratories Company Details
Table 82. ARUP Laboratories Business Overview
Table 83. ARUP Laboratories Hereditary Cancer Testing Product
Table 84. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 85. ARUP Laboratories Recent Development
Table 86. Myriad Company Details
Table 87. Myriad Business Overview
Table 88. Myriad Hereditary Cancer Testing Product
Table 89. Myriad Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 90. Myriad Recent Development
Table 91. NeoGenomics Company Details
Table 92. NeoGenomics Business Overview
Table 93. NeoGenomics Hereditary Cancer Testing Product
Table 94. NeoGenomics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 95. NeoGenomics Recent Development
Table 96. Blueprint Genetics Company Details
Table 97. Blueprint Genetics Business Overview
Table 98. Blueprint Genetics Hereditary Cancer Testing Product
Table 99. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 100. Blueprint Genetics Recent Development
Table 101. CellMax Life Company Details
Table 102. CellMax Life Business Overview
Table 103. CellMax Life Hereditary Cancer Testing Product
Table 104. CellMax Life Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 105. CellMax Life Recent Development
Table 106. Fulgent Genetics Company Details
Table 107. Fulgent Genetics Business Overview
Table 108. Fulgent Genetics Hereditary Cancer Testing Product
Table 109. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 110. Fulgent Genetics Recent Development
Table 111. Strand Life Sciences Company Details
Table 112. Strand Life Sciences Business Overview
Table 113. Strand Life Sciences Hereditary Cancer Testing Product
Table 114. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 115. Strand Life Sciences Recent Development
Table 116. Myogenes Company Details
Table 117. Myogenes Business Overview
Table 118. Myogenes Hereditary Cancer Testing Product
Table 119. Myogenes Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 120. Myogenes Recent Development
Table 121. LabCorp Company Details
Table 122. LabCorp Business Overview
Table 123. LabCorp Hereditary Cancer Testing Product
Table 124. LabCorp Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 125. LabCorp Recent Development
Table 126. Quest Diagnostics Company Details
Table 127. Quest Diagnostics Business Overview
Table 128. Quest Diagnostics Hereditary Cancer Testing Product
Table 129. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 130. Quest Diagnostics Recent Development
Table 131. Pathway Genomics Company Details
Table 132. Pathway Genomics Business Overview
Table 133. Pathway Genomics Hereditary Cancer Testing Product
Table 134. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2020-2025) & (US$ Million)
Table 135. Pathway Genomics Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Hereditary Cancer Testing Picture
Figure 2. Global Hereditary Cancer Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hereditary Cancer Testing Market Share by Type: 2024 VS 2031
Figure 4. RNA Testing Features
Figure 5. DNA Testing Features
Figure 6. Global Hereditary Cancer Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Hereditary Cancer Testing Market Share by Application: 2024 VS 2031
Figure 8. Breast Cancer Case Studies
Figure 9. Gastrointestinal Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Respiratory/Lung Cancer Case Studies
Figure 12. Other Cancers Case Studies
Figure 13. Hereditary Cancer Testing Report Years Considered
Figure 14. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Hereditary Cancer Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Hereditary Cancer Testing Market Share by Region: 2024 VS 2031
Figure 17. Global Hereditary Cancer Testing Market Share by Players in 2024
Figure 18. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2024
Figure 20. North America Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 22. United States Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 26. Germany Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Hereditary Cancer Testing Market Share by Region (2020-2031)
Figure 34. China Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 42. Mexico Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Hereditary Cancer Testing Market Share by Country (2020-2031)
Figure 46. Turkey Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Hereditary Cancer Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 50. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 51. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 52. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 53. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 54. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 55. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 56. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 57. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 58. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 59. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 60. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 61. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 62. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 63. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 64. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 65. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 66. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232